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 Abstract 
Accumulation of Aβ peptides in the human brain is a canonical pathological hallmark 
of Alzheimer’s disease (AD). Recent work in Aβ-overexpressing transgenic mice 
indicates that elevated brain Aβ levels can be associated with aberrant epileptiform 
activity. In line with this, such mice can also exhibit altered intrinsic excitability (IE) of 
cortical and hippocampal neurons: these observations may relate to the increased 
prevalence of seizures in AD patients. In this study we examined what changes in IE 
are produced in hippocampal CA1 pyramidal cells following 2-5 hours treatment with 
an oligomeric preparation of synthetic human Aβ1-42 peptide. Whole cell current 
clamp recordings were compared between Aβ-(500 nM) and vehicle-(DMSO 0.05%) 
treated hippocampal slices obtained from mice. The soluble Aβ treatment did not 
produce alterations in sub-threshold intrinsic properties including membrane potential, 
input resistance and hyperpolarization activated “sag”. Similarly, no changes were 
noted in the firing profile evoked by 500 ms square current supra-threshold stimuli. 
However, Aβ 500 nM treatment resulted in the hyperpolarization of the action 
potential (AP) threshold. In addition, treatment with Aβ at 500 nM depressed the 
after-hyperpolarization (AHP) that followed both a 1 single AP or 50Hz trains of 
between 5 and 25 APs. These data suggest that acute exposure to soluble Aβ 
oligomers affects IE properties of CA1 pyramidal neurons differently from outcomes 
seen in transgenic models of amyloidopathy. However, in both chronic and acute 
models the IE changes are towards hyper-excitability, reinforcing the idea that 
amyloidopathy and increased incidence in seizures might be causally related in AD 
patients. 
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Introduction 
Beta-amyloid peptides (Aβ) are widely believed to play an important role in 
the pathogenesis of Alzheimer’s disease (AD) (Hardy and Higgins, 1992; Pimplikar, 
2009). This family of peptides are produced by sequential enzymatic cleavage of the 
transmembrane protein amyloid precursor protein (APP) by the beta and gamma 
secretase complexes (Citron, 2004). Mutant forms of human APP, which are more 
readily processed to Aβ, result in familial early-onset forms of AD, as do mutations in 
the presenillins, key components of the gamma secretase complex that is involved in 
enzymatically liberating Aβ from APP (Chow et al., 2010). CNS accumulation of 
soluble Aβ occurs early in the disease process and grows as pathology becomes 
more advanced and Aβ-rich amyloid plaques also appear within the neuronal 
parenchyma (Jacobsen et al., 2006; Naslund et al., 2000). 
Numerous neurophysiological studies of transgenic mice which overproduce 
Aβ have been carried out over the last 15 years in the attempt to understand how 
AD-associated Aβ pathology disturbs CNS function (Randall et al., 2010). These 
studies have frequently concentrated on the analysis of synaptic function and 
plasticity in hippocampus and cerebral cortex (Fitzjohn et al., 2008; Jacobsen et al., 
2006; Tamagnini et al., 2012; Witton et al., 2010). More recent studies, including our 
own, have looked beyond synaptic function and have started to uncover significant 
alterations in the intrinsic excitability (IE) of single neurones in transgenic mice that 
over-produce Aβ . Such changes to IE have been reported in both excitatory and 
inhibitory neurones of the hippocampus (Brown et al., 2011; Hazra et al., 2013; 
Kaczorowski et al., 2011; Kerrigan et al., 2013; Minkeviciene et al., 2009; Wykes et 
al., 2012), the cortex (Hazra et al., 2013; Verret et al., 2012) and cerebellum (Hoxha 
et al., 2012). Clearly, such alterations to neuronal IE have to be considered along 
with changes to synaptic function if we are to understand the mechanisms through 
which elevated levels of Aβ change the activity of neuronal networks.  
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Our own work on IE has largely focused on hippocampal CA1 pyramidal cells 
(CA1-PC), and to date has involved investigation of four different transgenic Aβ 
overproducing mouse lines. We have identified changes to the bursting behaviour of 
CA1 pyramidal cells and associated changes to the spike after-depolarization (Brown 
et al., 2011; Kerrigan et al., 2013). We also found differences in the action potential 
waveform and demonstrated that these likely arise, at least in part, from alterations to 
the levels of functional voltage-gated Na+ channels (Brown et al., 2011). 
Our work has led to us frequently being asked whether the changes in IE we 
see in Aβ overproducing transgenic mice can also be observed when acutely treating 
brain slices with an exogenous Aβ preparation. In the work presented here we 
address this question by measuring the IE properties of CA1 hippocampal neurons in 
brain slices pre-treated with 500 nM soluble human amyloid beta 1-42 peptides 
(hAβ1-42). The concentration employed here has been frequently used for in vitro 
studies of synaptic function and it has been shown to both impair (Lambert et al., 
1998; Lauren et al., 2009; Puzzo et al., 2005; Wang et al., 2004) and to facilitate (Li 
et al., 2009) hippocampal LTP.  
Methods 
Experimental animals 
Male C57-BL6/J mice aged 4-5 weeks were used for all experiments. These 
animals were group housed and maintained on a standard 12:12 hour light/dark cycle 
with access to food and water ad libitum.  
Preparation of brain slices 
All procedures were carried out in accordance with UK Home Office 
legislation set out in the Animals (Scientific Procedures) Act (1986). The preparation 
of horizontal ventral hippocampal slices was performed as previously described 
(Brown et al., 2011; Brown and Randall, 2009). In brief, mice were sacrificed by 
cervical dislocation and the brain was rapidly removed and transferred to an ice cold 
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(~4 °C), sucrose-based slicing solution comprising (in mM): sucrose, 189; D-glucose, 
10; NaHCO3, 26; KCl, 3; MgSO4, 5; CaCl2, 0.1; NaH2PO4, 1.25, continuously bubbled 
with carbogen (95% O2, 5% CO2 gas mixture). The cerebellum, frontal and dorsal 
parts were removed with single scalpel cuts. The sample was then mounted on a 
metal plate on the dorsal side (i.e. ventral side up) and 300 µm thickness horizontal 
sections were prepared using a Leica VT1200 vibratome. After sectioning, slices 
were submerged in a storage vessel which contained our standard artificial 
cerebrospinal fluid (aCSF) consisting of (in mM): NaCl, 124; KCl, 3; NaHCO3, 26; 
CaCl2, 2; NaH2PO4, 1.25; MgSO4, 1; D-glucose, 10 and equilibrated with carbogen. 
The slices were gradually heated to ~32-34 °C for 30 minutes, after which they were 
stored at room temperature for one hour prior to being treated with either Aβ1-42 
peptide or vehicle.  
 
Preparation and application of Aβ1-42  
A preparation of Aβ1-42 peptide containing low N oligomeric species was 
prepared as described elsewhere (Jo et al., 2011). In brief, synthetic human Aβ1-42 
was purchased from Tocris and dissolved in 100% HFIP (1,1,1,3,3,3-hexafluoro-2-
propanol) to a concentration of 1 mgml-1. This solution was incubated at room 
temperature (RT) for 1 hr, vortexing every 5-10 min. The preparation was then 
sonicated for 10 min at RT. The HFIP/peptide solution was subsequently dried down 
under a very gentle stream of nitrogen. Following this, the dried peptide was re-
suspended in 100% DMSO to a concentration of 1 mM and incubated for 12 mins at 
RT, gently rotating the vial and vortexing every few minutes. This preparation was 
then pipetted into 10 µl aliquots and stored at -80oC. On the day of use, a single 
aliquot was rapidly thawed and 90 µl of PBS 0.1M added before performing 90-120 
min of rotation and gentle agitation. Following this the Aβ preparation was finally 
diluted 1:2000 into standard aCSF to a final Aβ concentration of 500 nM and applied 
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to slices for 2-5 hrs prior to electrophysiological recording. Control slices were 
exposed for a similar period to vehicle only (0.05% DMSO); use of this vehicle control 
group is particularly important as we have shown that this concentration of DMSO 
can alone change IE of cortical and hippocampal neurons (Tamagnini et al., 
2014).Notably, Aβ was not applied during the recording phase of our experiments, 
thus any changes observed arise from the prior period of pre-treatment performed 
before the tissue was transferred to the electrophysiological recording setup.  
The most commonly reported neurophysiological actions of oligomeric Aβ 
preparations are on long-lasting, activity-dependent, forms of synaptic plasticity such 
as long-term potentiation (LTP) and long-term depression (Randall et al., 2010). Pre-
incubating cortical slices with the Aβ preparation we employ here is able to reliably 
modify synaptic plasticity, completely abolishing the LTD in perirhinal cortex that can 
be evoked using a 5 Hz conditioning stimulus (SS, JB and AR unpublished 
observations).  
Electrophysiological methods 
Effects of exogenous Aβ on IE were studied using single cell patch clamp 
recording from CA1-PC. The recording methods we employed are very similar to 
those we used for our previous studies of intrinsic properties of this cell type in both 
Aβ-overproducing transgenic mice and healthy aged animals (Brown et al., 2011; 
Kerrigan et al., 2013; Randall et al., 2012). In brief, slices were placed into a 
submersion style recording chamber which was continuously perfused (~2 ml.min-1) 
with carbogen-equilibrated aCSF at 33 ± 1°C. CA1 pyramidal neurones in the CA1 
subfield of the hippocampus were visually identified using infra-red (IR) differential 
interference contrast optics. Pipettes were fabricated from borosilicate glass and 
were fire polished such that their resistance was 2.5-4.5 MΩ when filled with pipette 
solution. The pipette solution consisted of (mM): K-gluconate, 135; NaCl, 5; K-
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HEPES, 10; EGTA, 0.2; Na-GTP, 0.3; Mg-ATP, 4; Biocytin 13.4, Alexafluor 488 
hydrazide 0.03-0.06, pH 7.3, 280-290 mOsm.  
After forming the giga-seal and then entering the whole cell configuration in 
voltage-clamp mode, the amplifier was immediately switched to bridge-mode current-
clamp in which all experiments were performed. The pairing of the pipette solution 
and the aCSF produces a liquid junction potential error of 15 mV; this was corrected 
for arithmetically in all data sets. All recordings were made using a MultiClamp 700B 
amplifier (Molecular Devices, Union City, CA). Recordings were lowpass filtered (5-
10 kHz) and then digitised (20-100 kHz) with a Digidata 1440 and stored on a 
personal computer using pClamp10 electrophysiology software.  
In vitro electrophysiology protocols and data analysis 
Analysis of current-clamp recordings, including action potential waveform 
analysis was carried out with custom-written routines within the Matlab environment. 
Resting potential was measured as soon as possible after starting recording. 
Following determination of resting potential, for all other measurements the pre-
stimulus membrane potential was set to -80 mV (this value includes the junction 
potential correction - the amplifier reads -65 mV during the experiment) using the 
appropriate amount of current injection (x = Figure 1). Membrane resistance was 
analysed in multiple ways. The first measure (Rin-exp) assessed resting input 
resistance independently of the “sag”-producing Ih activation that occurs during 
hyperpolarizing current steps. This was calculated using Ohm’s law from the 
amplitude of an infinite time extrapolation of a single exponential curve fitted to the 
membrane charging response generated by a -100 pA current injection (Figure 1, 
arrow B). The exponential fit was made between points at 10% and 95% of peak 
amplitude. This fit was also used to determine membrane time constant and to 
determine one measure of the extent of sag (see below). Secondly, the reduced 
measure of input resistance which includes the contribution from additional Ih 
activation (Rin-ss) was calculated using Ohm’s law by determining the steady-state 
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(post-sag) voltage deflection produced by a 500 ms -100 pA stimulus (Figure 1, 
arrow C). Finally, the input resistance at -80 mV (Rin-slope) was also measured (as the 
reciprocal of slope conductance) using linear regression of the steady state voltage 
responses elicited by a series of 8 low amplitude (-50 to +30 pA), 500 ms duration 
current steps (Figure 3A).  
Hyperpolarization-activated sag was measured in two ways. The first 
measurement (sagsub) simply expressed the difference between the peak (Figure 1, 
arrow A)  and steady state hyperpolarizations produced by a 500 ms -100 pA current 
injection as a percentage of the peak hyperpolarization, i.e. 100 * (A-C)/A (in Figure 
1). The second measure of sag (sagfit) measured the decay in response relative to 
the amplitude of the infinite time extrapolation used to determine Rin-exp i.e. 100* (B-
C)/B (Figure 1). In addition to sag, the amplitude of the sag-related rebound 
depolarization was also measured relative to the pre-stimulus membrane potential 
(Figure 1, arrow D). All the passive properties were statistically compared between 
groups using unpaired Student’s t-test. 
Membrane resonance was measured with standard “ZAP” protocols in which 
a low amplitude sinusoidal current injection of linearly increasing frequency was 
applied to the cell causing voltage deflections of around 5 - 10 mV, as previously 
described (Hu et al., 2002). The impedance profile was calculated as the ratio 
between the fast Fourier transform of the voltage response (V(fft)) and current 
injection (I(fft)): Z = V(fft)/I(fft); the impedance vs frequency profile was subsequently 
smoothed with a moving average function with a span of 35 data-points. The 
parameters analyzed to test the effect of treatment on the sub-threshold resonance 
properties of CA1 pyramidal neurons were the peak frequency, the peak impedance 
and the quality factor of the resonator Q; unpaired Student’s t-test was used to test 
the effect of treatment on resonance. 
Depolarizing current injections of 500 ms duration and amplitude varying 
stepwise from 50 to 300 pA were used to elicit action potential (AP) firing. From these, 
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the relationship between the stimulus amplitude and the number and pattern of APs 
elicited was examined. The firing properties illustrated in Figure 4-5 were examined 
between groups using two-way analysis of variance (ANOVA). To assess individual 
AP waveforms, the first spike fired by a 300 pA current injection was analysed, as 
this size of stimulus elicited an AP in all cells. AP threshold was determined from 
phase plots as the voltage at which dV/dt surpassed 15 V.s-1 (Naundorf et al., 2006). 
Spike width was measured at -15 mV which is approximately halfway between 
threshold (~-60 mV) and action potential peak (~+30 mV). The AP properties were 
statistically compared between groups using unpaired Student’s t-test. 
Voltage responses were also measured to single, brief (2 ms), strong (2 nA) 
current injections. This stimulus usually elicits a single AP which is followed in 
hippocampal pyramidal cells by a fast ADP, followed in turn by a brief small AHP. 
Unpaired Student’s t-test was used to compare the ADP and AHP elicited by a single 
spike. 
Finally, to further test the effect of treatment on post-burst firing AHP, trains of 
5-10-15-20-25 2ms/2nA square current pulses were delivered at a frequency of 50Hz; 
the medium AHP was measured as the most hyperpolarized point in the 500 ms 
following the descending phase of the last AP reaching 0 mV. Two way ANOVA was 
used to statistically assess the effect of treatment on the medium AHP amplitude 
elicited by 50 Hz spike trains. 
 
Results 
Our studies of the effects of exogenous Aβ on IE of CA1-PC were focused on 
slices treated with 500 nM peptide (initial monomer concentration). Although very 
high compared to global average levels in AD brain measured in Aβ-overexpressing 
transgenic mouse models of amyloidopathy (~0.5 nM) (Waters, 2010), this 
concentration  is probably the most commonly employed in neurophysiological 
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studies of brain slices, including a large body of data on Aβ effects on synaptic 
plasticity (Lambert et al., 1998; Lauren et al., 2009; Ma et al., 2011; Parameshwaran 
et al., 2007; Puzzo et al., 2005; Randall et al., 2010; Wang et al., 2004). The 
concentration of Aβ 1-42 soluble oligomers tends to decrease with age; this is 
particularly true in AD patients, where the ratio between the insoluble:soluble fraction 
of Aβ is significantly higher, as revealed in >60 years pot-mortem human AD brains 
versus age-matched controls, presumably because of the aggregation of soluble Aβ 
into insoluble fibrils and plaques (van Helmond et al., 2010). The physiological 
relevance of using this concentration (500 nM) relies on the fact that the average 
levels of Aβ 1-42 soluble oligomers in the AD brain can disguise the peri-plaque 
concentration gradient of this species, which might differentially affect the neuronal 
function depending on the distance from the plaque itself.  
Pre-exposure for 2-5 hrs duration to 500 nM of Aβ had no effect on resting 
membrane potential (Figure 2A). Figure 2B presents average voltage responses to -
100 pA and +50 pA current stimuli applied at a fixed pre-stimulus potential of -80 mV 
both for vehicle and Aβ treated cells. It is readily apparent that the responses are 
very similar. This is confirmed by the cell by cell analysis of responses to -100 pA 
current stimuli, presented in Figure 2C-H. Thus, membrane resistance measured as 
both Rin-exp and Rin-ss (see methods) was unaltered (Figure 2C and D). The sag 
observed in response to a -100 pA hyperpolarizing current step was not altered. This 
was the case when the sag was measured as peak hyperpolarization relative to the 
steady state (sagsub, Figure 2E) or using an exponential fit to the membrane charging 
(sagfit, Figure 2F); likewise the sag-related rebound depolarization observed on 
cessation of the current injection was also not altered following incubation in Aβ 
(Figure 2G). Membrane time constant was also not changed by Aβ application 
(Figure 2H). The lack of effect of Aβ on membrane resistance was also confirmed 
when an incremental series of small current pulses was applied to the cells and 
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voltage versus current plots constructed (Figure 3A to C). For mean values see Table 
1.  
 
The activation/deactivation properties of various ion channels with significant 
voltage-dependent gating near to resting potential can create membrane resonance 
in neurones. In CA1 pyramidal cells this is typically seen around 5 Hz and results 
from the activity of HCN channels and low threshold K+ channels such a Kv7 family 
members. We analysed resonance properties in 21 Vehicle and 21 hAβ 1-42 
oligomers treated neurones. As shown in Figure 4D there was no difference between 
the groups. This was the case for the peak resonant frequency, the peak impedance 
and the quality factor Q of the resonator (see Table 2). 
 
The data in Figures 2 to 3 indicate we were unable to find any significant 
difference in sub-threshold membrane properties between control cells and those 
exposed to 500 nM Aβ for between 2-5 hrs. This lack of alteration to sub-threshold 
intrinsic properties is in good agreement with our work in transgenic mice where the 
major differences are seen in supra-threshold parameters. Thus, to study AP firing 
patterns of CA1-PC, we depolarized the cells with 500 ms current injections ranging 
in amplitude from 50 to 300 pA (Figure 4A shows the response of an example cell 
from the two treatment groups at 3 different current intensities). The plot in Figure 4B 
presents the mean number of spikes fired for each stimulus amplitude (including 
sweeps where no spikes occurred). This illustrates that almost identical numbers of 
spikes were produced in the 25 hAβ 1-42 oligomers − and 24 vehicle-treated slices 
studied. A similar outcome is apparent from Figure 4C which also plots the number of 
spikes fired for each stimulus, but only includes data from sweeps in which at least 1 
action potential was produced. For the 300 pA current injection the mean peak 
amplitude of the first 10 APs fired is shown in Figure 4D: no difference was observed 
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between the two treatments. Finally, no difference was observed in the fraction of 
cells firing one or more APs in response to a depolarizing current step of increasing 
intensity (Figure 4E).  
In aged PSAPP transgenic mice stimulated with relatively weak 
suprathreshold current injections, the pattern of AP firing in CA1-PC during 500 ms 
depolarizations was significantly altered compared to wild-type littermates (Brown et 
al 2011). In particular the transgenic mice exhibited a more pronounced burstiness 
soon after the onset of the current injection. We have recently seen a somewhat 
similar phenotype in the PDAPP transgenic line (Kerrigan et al., 2013). Such an 
effect is best illustrated in plots of instantaneous spiking frequency versus spike 
interval number. Such plots, comparing hAβ 1-42 oligomers− and vehicle-treated 
slices for 4 different levels of current injection, are shown in Figures 5A-D. It is clear 
that a short exposure to a high (500 nM) concentration of hAβ 1-42 oligomers, was 
not able to alter the AP by AP profile of instantaneous frequency in a way similar to 
that we reported in the Aβ overproducing transgenic mice (Brown et al., 2011; 
Kerrigan et al., 2013). 
 The post-spike ADP is a major determinant of burstiness in hippocampal 
pyramidal cells, and was larger in PSAPP mice (Brown et al., 2011). In this study, 
commensurate with the lack of change in AP firing dynamics, the ADP amplitude 
following a single spike  was not modified in hAβ 1-42 oligomer-treated slices 
(Vehicle 16.6 ± 1.2 mV, versus hAβ 1-42 oligomer  15.2 ± 1.1 mV, p=0.4). Thus, an 
acute 2-5 hour treatment with 500 nM hAβ 1-42 oligomers was not sufficient to 
produce the same changes in IE and AP firing previously observed in Aβ-
overproducing transgenic mice.  
In CA1-PC of PSAPP transgenic mice, as well as finding more “bursty” firing 
patterns, we also identified changes to the properties of individual action potentials 
(Brown et al 2011). For example, analysis of the first AP fired by 300 pA depolarizing 
Page 12 of 38
John Wiley & Sons
Hippocampus
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
This article is protected by copyright. All rights reserved.
current injections revealed that, on average, APs rose more slowly, had a lower 
zenith, and were also narrower in width at -15 mV. The former two changes are likely 
to result from the deficit in Na+ channels we described in CA1-PC using macropatch 
recording (Brown et al 2011). In this light, we examined if acute hAβ 1-42 oligomers 
treatment was able to modify the AP waveform in CA1-PC. To do this we examined 
the properties of the first AP fired in response to a 300 pA stimulus (as we had done 
in our work in transgenic mice). The amplitude of the AP was not modified (Figure 6A, 
and see also the first data point in Figure 4D), nor was the AP maximum rate of rise 
(RoR) (Figure 6B). Furthermore, the spike width was not different when measured at 
-15 mV (Figure 6C) or at spike threshold (Vehicle, 1.59 + 0.09 ms versus hAβ 1-42 
oligomer-treated 1.66 ± 0.12 ms, not shown). The spike threshold, however, was 
altered, having moved some 3 mV more negative in the hAβ 1-42 oligomer−treated 
neurones (Figure 6D). Given that resting potentials were similar in both groups 
(Figure 2A) this means that CA1-PC in hAβ 1-42 oligomer-treated slices require 
around 15% less depolarizing drive to reach spike threshold (see Table 3 for 
averages and SEM).  
Following short bursts of action potential firing, hippocampal pyramidal cells 
exhibit an after-hyperpolarization (AHP). This size of this after-potential is reported to 
change during normal aging (Oh et al., 2010), an effect that has been postulated to 
play a role in age-related cognitive decline (Luebke and Amatrudo, 2012; Oh et al., 
2010). Previous reports suggests that this AHP is modified in Aβ-overproducing mice, 
although both increases (Kaczorowski et al., 2011) and decreases have been 
reported (Kerrigan et al., 2013).  
To investigate how Aβ affected AHPs following bursts of AP firing we used 
repeated brief, strong current injections (2 nA, 2 ms) to induce CA1-PCs to fire trains 
of AP at 50 Hz. The trains consisted of 5, 10, 15, 20 or 25 APs. In CA1-PC from 
control slices such stimuli reliably evoked a mAHP; in contrast, mAHPs were 
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completely absent in many cells from Aβ treated slices. Furthermore in the peptide 
treated cells a post-burst ADP not seen in control cells and lasting a few hundred ms 
was apparent. This is illustrated in Figure 7A which presents the group average 
voltage responses following 25 AP evoked at 50 Hz compiled from 9 Aβ-treated and 
14 control CA1 pyramidal cells. An essentially similar finding was made for 50 Hz AP 
trains comprised of 5, 10, 15 or 20 stimuli. The maximal mAHP amplitude seen 
following each of the 50 Hz trains was measured in each cell and compared across 
groups. This revealed a significant depression of the mAHP following Aβ  (500 nM) 
treatment (n=9) compared to vehicle treated slices (n=14, P<0.005). Similarly the 
AHP observed in CA1-PC after a single AP (elicited with a single 2 nA current 
injection lasting 2 ms) was also around 50% smaller in Aβ treated slices (Control: 1.2 
± 0.2 mV (n=17) versus Aβ 0.6 ± 0.1 mV, (n=17), p<0.02).  
 
Discussion 
 Based on multiple lines of evidence, soluble Aβ peptides are still regarded by 
many as key pathological species in AD, potentially contributing to both pathogenesis 
and disease progression (Hardy and Selkoe, 2002; Hardy and Higgins, 1992). Thus, 
in attempts to better understand the patho-physiological mechanisms underlying AD, 
numerous studies focusing on the biological actions of acutely administered 
exogenous soluble Aβ peptides have been made both in vivo (An et al., 2013; 
Brouillette et al., 2012; Klyubin et al., 2014) and in vitro (Lambert et al., 1998; Lauren 
et al., 2009; Li et al., 2009; Minkeviciene et al., 2009; Parameshwaran et al., 2007; 
Puzzo et al., 2005; Wang et al., 2004). The other major approach to understanding 
Aβ biology focuses on the use of mouse lines transgenically engineered to 
overproduce Aβ peptide species, a model of more chronic exposure to Aβ species.  
Some recent studies, including our own have used Aβ-overproducing mice to 
identify changes to the intrinsic electrical properties of neurones (Brown et al., 2011; 
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Hazra et al., 2013; Hoxha et al., 2012; Kaczorowski et al., 2011; Kerrigan et al., 2013; 
Randall et al., 2012; Wykes et al., 2012). Due to the nature of these models, when 
studied experimentally brain tissues might have been exposed to elevated Aβ levels, 
in vivo, for up to ~2 years, a time only limited by the natural lifespan of laboratory 
mice. In this study we investigated the effect on IE of CA1 pyramidal cells of acute in 
vitro exposure to soluble hAβ 1-42 oligomers. Clearly this is a very different scenario 
to chronic in vivo exposure, but one that has been frequently employed by others 
with interests in determining the multifaceted functional actions of Aβ peptides. 
 Our investigations were based on hAβ pre-treatment of acutely prepared 
mouse hippocampal slices for a period of 2-5 hours. This time was selected as a 
balance between allowing a reasonable time for Aβ effects to be produced and 
consideration of the inevitable decline in the health of brain slices that occurs with 
time in vitro. Slices were treated with either soluble 1-42 oligomers 500 nM (which 
included 0.05% DMSO) or vehicle alone (i.e. DMSO 0.05%). It appears especially 
important to perform the correct vehicle control in studies such as this as we have 
recently demonstrated that 2-5 hours treatment with 0.05% DMSO alters IE 
properties of both CA1-PC and pyramidal neurons in perirhinal cortex (Tamagnini et 
al., 2014). Similarly investigations into the consequences of acute exogenous Aβ 
exposure have been clouded over the years by debate over the “right” peptide 
preparation to use. We used an Aβ preparation that was at least shown to be active 
against synaptic plasticity both by others (Jo et al., 2011) and also within our own 
group (see methods). 
In previous reports by other groups, certain neurophysiological effects of Aβ 
peptides have been reported to be detectable within very short exposure periods. For 
example, the inhibition of long-term potentiation is reported to require less than 1 
hour of Aβ pre-treatment and maybe as little as 10 minutes in vivo (Cullen et al., 
1997; Cullen et al., 1996); indeed this group, who are perhaps the most prolific 
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investigators of Aβ and hippocampal synaptic plasticity, use a standard treatment 
time in vivo of 15 mins. Also with regard to the time-course of action of exogenous Aβ 
it is has also been reported that a single in vivo injection can inhibit induction of 
synaptic plasticity 7 days later (Klyubin et al., 2014). Our experiments employed what 
has been perhaps the most commonly utilised concentration of exogenous Aβ for in 
vitro studies of brain slices, namely 500 nM. We found that pre-treatment for 2-5 
hours with this concentration of peptide (the same treatment that will inhibit synaptic 
plasticity) left many basic intrinsic properties of CA1-PC unaltered, including resting 
potential, input resistance and any other sub-threshold properties. Aβ treatment did, 
however, produce both a negative shift in action potential threshold and a depression 
of the substantial mAHP that usually arises after 50Hz trains of AP firing. Indeed, in 
many cells the mAHP was not only lost but appeared to be replaced with a slow ADP.  
A more hyperpolarized AP threshold and a depressed AHP (and appearance 
of an ADP) after spike firing are both actions that would typically be regarded as a 
net increase in excitability. For the former this is because following Aβ exposure a 
smaller change from resting potential would be required to induce AP production. For 
the latter, the changes to spike afterpotential would enable spiking to be re-
established more readily after a prior burst. Certainly hyperexcitability in cortical and 
hippocampal circuits of Aβ over-expressing mice is an increasingly reported 
phenomenon, and has been discussed in the framework of the increased risk of 
seizures found in AD suffers, most notably in early onset cases: the changes to 
intrinsic properties described here may contribute to this phenomenon (Brown et al., 
2011; Kerrigan et al., 2013; Minkeviciene et al., 2009; Palop et al., 2007).  
An interesting insight from these results is the comparison with transgenic 
models of amyloidopathy, where the exposure of CA1 pyramidal neurons to elevated 
Aβ is chronic, typically lasting months or longer. Recent studies showed that PSAPP 
(Brown et al., 2011), PDAPP (Kerrigan et al., 2013) and CRND8 (Wykes et al., 2012) 
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mice do not show any difference from wild-types in the AP threshold of CA1-PC, but 
they all consistently show a decreased spike width - something we have also found in 
Tg2576 and TAS-TPM Aβ overproducing mice (unpublished observations). A 
possible explanation of this discrepancy between the chronic and the acute models 
of amyloidopathy might be the increased potassium channel expression, described 
as an early consequence in one transgenic model (Wykes et al., 2012). Such a 
change could act as a compensatory response to a decreased AP threshold arising 
from more acute exposure to Aβ. Indeed, the presence of time-dependent 
compensatory changes arising from brain plasticity are a constant challenge for 
those working with chronic disease models.   
The global Aβ concentration in the brain of Aβ overproducing transgenic mice 
is likely to be much lower than the 500 nM Aβ1-42 concentration employed here for 
acute slice pre-treatment. Indeed, in terms of clinical AD, the commonly employed Aβ 
concentration we used to treat slices with is very high. Mean global levels of soluble 
Aβ1-42 in the brains or CSF of AD sufferers are typically in the low pM range. It 
remains possible, however, that higher levels are present within certain CNS niches, 
for example in the vicinity of amyloid plaques or perhaps within synaptic clefts.  
When presenting our previous research on transgenic mice that overproduce 
Aβ we have often been asked if we observe similar behaviours when applying 
soluble Aβ peptides acutely. By performing many similar measurements to those we 
made previously in PSAPP (Brown et al., 2011), PDAPP (Kerrigan et al., 2013) and 
other mice this study has partially addressed this question here. It is, however, worth 
considering if it would even be reasonable to expect to see similar changes in Aβ 
overproducing transgenic mice and following acute Aβ treatment. Although both 
interventions involve exposure to Aβ the nature of the exposure is very different in 
each case. Transgenic mice engineered to overproduce Aβ start life with normal, low 
Aβ loads and generate elevated levels over many months, although in different 
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mouse-lines the rate of development and extent of the amyloid pathology is different 
(Lithner et al., 2011). However, at the time-points they are usually studied, the 
circuits under investigation have often experienced an elevated Aβ load for many 
months. Furthermore, as indicated above, the CNS is very plastic exhibiting multiple 
adaptive mechanisms including changes to gene expression patterns that can 
remodel the physiology of cells. Thus if they are perturbed acutely, for example by Aβ, 
the cells of the CNS are very likely, over time, to reshape their physiology in multiple 
ways. This could likely lead to very different neurophysiological outcomes those 
produced by acute Aβ exposure over a few hours. Relating to this, AD sufferers are 
now thought to reflect outcomes of detrimental processes that have been established 
many years, some of which may involve Aβ- so the transgenic mouse may be a 
better model of aspects of the pathophysiology of the AD brain during the 
progression phase, whereas the acute Aβ actions may tell us important information 
about the early biological processes that trigger subsequent adaptive and 
pathological changes.  
It may be useful in future to investigate the cellular basis of the changes to IE 
that are produced by acute Aβ treatment. The altered AP threshold is likely to be a 
consequence of a change to voltage-gated Na+ channels, this is something which 
could possibly be investigated with voltage-clamp studies of nucleated macropatches 
an approach we have used previously to identify Na+ channel changes underlying 
altered IE both in mouse models of amyloidopathy (Brown et al., 2011) and 
associated with normal aging (Randall et al., 2012). Given the prominent role of 
intracellular Ca2+ in CA1-PC AHPs, the altered afterpotentials seen following Aβ 
treatment may reflect a change to activity-dependent intracellular Ca2+ signalling, 
something that might best be examined further with cellular imaging methodologies.        
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Figure Legends 
Figure 1. Schematic representation of the determination of passive 
membrane properties from a hyperpolarizing current step. In order to 
assess IE properties of CA1 pyramidal neurons, whole cell current clamp 
recordings were performed. For each recording, a “holding” current (x pA) was 
injected in order to keep the unstimulated Vm  at the fixed value of -80mV. A 
500ms long, -100 pA amplitude current was injected in order to assess the 
passive properties of the neuronal membrane. The input resistance was 
measured at the steady state of the Vm deflection (arrow C) or at the infinite 
time extrapolation (arrow B) of the single exponential fit to points between 
10%-95% of the negative peak (arrow A). The exponential fit was also used to 
calculate the membrane time constant τ. Sag was calculated both from the 
decline from the observed negat ve peak ((A-C)/A)) and from the Vm 
extrapolated at the infinite time of the exponential fit ((B-C)/A)). Sag is 
mirrored by a positive rebound of the potential following the interruption of the 
hyperpolarizing current step (D). 
 
Figure 2. Pre-treatment with soluble hAβ 1-42 oligomers does not alter 
subthreshold intrinsic properties in CA1-PC  (A) A scatter/box plot of zero 
current potential recorded from vehicle and Aβ pre-treated CA1-PC. In this 
and all other similar plots, the symbols to the left represent data from 
individual neurones, whereas the box to the right plots the mean (central 
symbol) plus the upper and lower bounds of the standard error and the 
median. In this and all other figures data from vehicle treated neurones are 
presented in black and data from Aβ pre-treated cells are shown in grey. (B) A 
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plot of the average voltage response to both -100 (downwards) and +50 pA 
(upwards) current stimuli applied to CA1-PC. The thicker central line 
corresponds to the mean whereas the two adjacent thinner lines represent the 
bounds encompassed by 1 standard error of the mean. (C-H) Scatter plots of 
sub-threshold intrinsic properties derived from -100 pA stimuli applied at a 
fixed membrane potential of -80 mV.  
 
Figure 3. Soluble hAβ 1-42 oligomer pre-treatment does not alter 
membrane resistance and impedance in CA1-PC (A) Voltage responses 
from an example CA1-PC elicited by a series of 500 ms current stimuli varying 
in amplitude between -50 and +30 pA (top). (B) Pooled data from a number of 
recordings similar to and including the one shown in (A). The graph plots 
steady-state voltage deflection versus current stimulus: the slope of the 
interpolated straight line for each group represents the input resistance, in 
accordance with the Ohm’s law V=RI. C) A scatter plot of input resistance 
derived from recordings like that in (A). Each symbol represents the slope-
derived input resistance derived from a straight line fit through all the data 
points obtained from a single recording. D) The top panel shows a plot of 
mean impedance versus stimulus frequency for vehicle control (black) and Aβ 
1-42 500 nM-treated (grey) CA1-PC. The thicker central line represents the 
mean values, and the dashed lines the bounds of 1 SEM. The bottom panel 
shows an example trace of the Vm of CA1 pyramidal cell resonating in 
response of the injection of a sinusoidal current injection of increasing 
frequency. The impedance Z(Ω) is measured as Z=V(fft)/I(fft). The quality 
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factor of the resonator, Q, is calculated as the ratio between the Z at peak 
frequency and Z the frequency of 1 Hz (Q = Zpeak/Z1Hz). 
 
Figure 4. Pre-treatment with soluble hAβ 1-42 oligomers does not alter 
the firing properties of CA1-PC (A) Example traces from either vehicle or Aβ 
treated CA1-PC firing APs in response of supra-threshold 500 ms current 
stimuli. (B) The treatment with Aβ oligomers did not have a significant effect 
on the overall number of APs fired by CA1-PC in response to 50-300 pA, 500 
ms current stimuli, including or excluding (C) the cells that did not fire at least 
1 action potential. (D) Pre-treatment with Aβ oligomers did not have a 
significant effect on AP zenith measured within the first 10 spikes. (E) The 
treatment with Aβ oligomers did not alter the fraction of firing cells observed at 
each applied current intensity.  
 
Figure 5. Pretreatment with soluble hAβ 1-42 oligomers does not alter 
the firing dynamics of CA1-PC The instantaneous frequency of AP firing in 
CA1-PC is higher during the early part of a depolarizing stimulus and 
subsequently accommodates to a steady slow rate of firing. Treatment with 
Aβ oligomers did not alter the “burstiness” of CA1-PCs (A-D). 
 
Figure 6. Soluble hAβ 1-42 oligomer pre-treatment results in the 
hyperpolarization of action potential threshold. (Top left)  The average 
waveforms ± SEM of the first action potential fired in response of a 500 ms 
duration 300 pA amplitude current stimulus for vehicle (black) or Aβ oligomers 
treated (grey) cells, note the more hyperpolarized AP threshold in the latter 
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group. (Top right) A phase-plane plot of mean AP RoR vs Vm for the two 
treatment groups. Scatter/box plots describing the effect of Aβ treatment on 
the single AP properties, only AP threshold is significantly altered, *= p<0.05. 
 
Figure 7. Soluble hAβ 1-42 oligomer pre-treatment impairs post-burst 
AHP. Group average post AP-train responses from 9 Aβ-treated and 14 
control cells. 25 AP were evoked in each cell as shown by the arrow. The 
post-stimulus mean voltage responses are shown by the thick black traces 
and the extent of the standard error of the mean is represented by the grey 
lines. The dashed horizontal line represents the resting potential prior to the 
AP train (i.e. -80 mV); thus afterpotentials below this are AHPs and 
afterpotentials above it are ADPs. Note the presence of a clear AHP lasting 
around 150 ms in the control cells whereas Aβ treated cells are characterized 
by an ADP.   
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Table 1. Comparison of passive membrane properties of CA1 pyramidal 
neurons pre-treated with vehicle (DMSO=0.05%) vs hAβ 1-42 oligomers 500 
nM. 
Veh n=24 hAβ 1-42 nM n=25 
Property Average SEM Average SEM P 
RMP (mV) -73.76 1.32 -75.04 1.15 0.47 
Rin-ss (MΩ) 78.36 5.36 80.88 7.03 0.78 
Rin-exp (MΩ) 110.28 6.89 114.68 12.03 0.75 
sag_sub (%) 23.47 1.18 21.85 1.31 0.36 
sag_fit (%) 29.36 1.20 28.13 1.68 0.56 
Rebound (mV) 2.20 0.16 2.16 0.23 0.87 
tau (ms) 14.34 0.94 15.96 1.30 0.32 
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Table 2. Comparison of resonance properties of CA1 pyramidal neurons pre-
treated with vehicle (DMSO=0.05%) vs hAβ 1-42 oligomers 500 nM. 
  
Veh n=21 hAβ 1-42 nM n=21 
P  Mean  SEM  Mean  SEM  
Peak frequency (Hz) 5.17 0.43 4.58 0.51 0.38   
Q  1.21 0.03 1.15 0.02 0.18   
Peak Z (MΩ) 105.83 9.31 115.99 8.79 0.43   
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 Table 3. Comparison of AP properties in control  CA1 pyramidal neurons pre-
treated with vehicle (DMSO=0.05%) vs hAβ 1-42 oligomers 500 nM. 
Veh n=24 hAβ 1-42 nM n=25 
P Mean  SEM  Mean  SEM  
AP_peak (mV) 34.46 1.50 33.95 1.05 0.78 
AP_width (ms) 0.75 0.03 0.69 0.02 0.10 
AP_thres (mV) -54.98 0.70 -57.40 0.79 0.03 
AP_max_dvdt (Vs
-1
) 530.42 18.85 549 16.09 0.45 
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